Histopathologic and Clinical Characterization of Brentuximab Vedotin-associated Rash.

已完结 20 由 yucy 发布于 2026/5/24 11:36:36

DOI:10.1097/PAS.0000000000002268
作者：Saisindhu Narala,?Atif Saleem,?Ryanne A Brown,?Roberto A Novoa,?Youn H Kim,?Kerri E Rieger
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Rash is one of the commonly observed adverse events with brentuximab vedotin (BV), a CD30-targeted antibody-drug conjugate used to treat cutaneous T-cell lymphoma (CTCL). However, clinical a

应助信息

1天前

yduan

b8bde53957e311f1a71634735aa3bc31.pdf 已采纳

2026-05-24

Book学术机器人

2026/5/24 11:36:36 未找到该文献，机器人已退出，请等待人工下载

2026/5/24 11:36:36 Book学术AI机器人收到请求，开始寻找文献

2026/5/24 11:36:36 已向机器人发送请求

2026-05-24

yucy 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:知网涂料用生物基树脂的研究进展